An empirical modeling platform to evaluate the relative control discrete CHO cell synthetic processes exert over recombinant monoclonal antibody production process titer.
An empirical modeling platform to evaluate the relative control discrete CHO cell synthetic processes exert over recombinant monoclonal antibody production process titer.
复制标题
一个经验建模平台,用于评估相对控制离散 CHO 细胞合成过程对重组单克隆抗体生产过程滴度的影响。
DOI:
10.1002/bit.23146
复制
发表时间:
2011
影响因子:
3.8
通讯作者:
McLeod J
中科院分区:
文献类型:
--
作者:
McLeod J
In this study we have combined empirically derived mathematical models of intracellular Mab synthesis to quantitatively compare the degree to which individual cellular processes limit recombinant IgG4monoclonal antibody production by GS‐CHO cells throughout a state‐of‐the‐art industrial fed‐batch culture process. Based on the calculation of a production process control coefficient for each stage of the intracellular Mab synthesis and secretion pathway, we identified the major cellular restrictions on Mab production throughout the entire culture process to be recombinant heavy chain gene transcription and heavy chain mRNA translation. Surprisingly, despite a substantial decline in the rate of cellular biomass synthesis during culture, with a concomitant decline in the calculated rate constants for energy‐intensive Mab synthetic processes (Mab folding/assembly and secretion), these did not exert significant control of Mab synthesis at any stage of production. Instead, cell‐specific Mab production was maintained by increased Mab gene transcription which offset the decline in cellular biosynthetic rates. Importantly, this study shows that application of this whole‐process predictive modeling strategy should rationally precede and inform cell engineering approaches to increase production of a recombinant protein by a mammalian host cell—where control of productivity is inherently protein product and cell line specific. Biotechnol. Bioeng. 2011;108:2193–2204. © 2011 Wiley Periodicals, Inc.